Featured

Cavion Appoints Spyridon Papapetropoulos, M.D., Ph.D. as Executive Vice President, Research and Development and Chief Medical Officer

Home - CBIC

CHARLOTTESVILLE, Va.--()--Cavion, Inc., a clinical stage biopharmaceutical company, announced today that Dr. Spyridon "Spyros" Papapetropoulos has joined as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Papapetropoulos will lead Cavion’s research

Charlottesville Women in Tech